跳至主要内容
临床试验/NL-OMON20217
NL-OMON20217尚未招募不适用

Transcranial Alternating Current Stimulation (tACS) as a novel treatment option: a proof of concept study in Adult Classic Galactosemia

azM0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
azM
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient group
  • The patient may participate in the study, if they meet these criteria:
  • - Adult age: 18 years or older
  • - GALT enzyme activity below 10% and/or GALT gene severe disease causing mutations
  • - Motor sequencing and/or word productions problems
  • - Documented motor and language impairments
  • - Capable of giving informed consent
  • - The participants are screened pre and post intervention using standardized tests. Participants with abnormal scores in cognitive and/or motor domains are eligible.
  • Control group
  • Healthy controls are included if they meet the following criteria:
  • - Adult age: 18 years or older
  • - No motor, language and/or cognitive impairments
  • - Capable of giving informed consent

排除标准

  • A subject will be excluded from the study, if he meets these criteria:
  • - Motor and language problems due to other causes
  • - Psoriasis
  • - Epilepsy

研究者

发起方
azM

相似试验